SCHEMBL18178873

SCHEMBL18178873

CC(=O)Oc1cccc(CO)c1COc1ccc(C)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.48
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
FFAR4 Q5NUL3 3/20 0.40
PTPN1 P18031 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
TP53 P04637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 1/20 0.39
FFAR1 O14842 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178872 0.91 MRGPRX4 (0.49) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178879 0.89 MRGPRX4 (0.47) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178485 0.88 MRGPRX4 (0.46) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178077 0.88 MRGPRX4 (0.46) MRGPRX4SMN1; SMN2MEN1KMT2AFFAR4
SCHEMBL18178831 0.88 MRGPRX4 (0.46) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178896 0.88 MRGPRX4 (0.43) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18179000 0.88 PTPN1 (0.42) MRGPRX4LMNAKMT2APTPN1NPC1
SCHEMBL18178875 0.87 MRGPRX4 (0.52) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178842 0.87 MRGPRX4 (0.46) MRGPRX4LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18178874 0.84 MRGPRX4 (0.49) MRGPRX4LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MRGPRX4 167/4885LMNA 4171/4885SMN1; SMN2 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.